Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review
about
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewPathology and biology of radiation-induced cardiac diseaseCurrent Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with ThiazolidinedionesModulation of PPAR Expression and Activity in Response to Polyphenolic Compounds in High Fat DietsRole of Transcription Factors in Steatohepatitis and Hypertension after Ethanol: The Epicenter of MetabolismPeroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac FibrosisInterdependence of nutrient metabolism and the circadian clock system: Importance for metabolic healthMolecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASHThe Role of Dietary Protein and Fat in Glycaemic Control in Type 1 Diabetes: Implications for Intensive Diabetes ManagementExploiting host immunity: the Salmonella paradigmPhthalate exposure and childhood obesityEffects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cellsGene expression profile during proliferation and differentiation of rainbow trout adipocyte precursor cells.Maternal obesity, inflammation, and developmental programming.Caffeic acid and hydroxytyrosol have anti-obesogenic properties in zebrafish and rainbow trout modelsDiscovery of Novel Insulin Sensitizers: Promising Approaches and Targets.Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic DrugsDiosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease.Therapeutic Applications of Rose Hips from Different Rosa Species.Twist 1 regulates the expression of PPARγ during hormone-induced 3T3-L1 preadipocyte differentiation: a possible role in obesity and associated diseases.Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.Effects of pioglitazone mediated activation of PPAR-γ on CIDEC and obesity related changes in mice.Maternal high-fat diet modulates hepatic glucose, lipid homeostasis and gene expression in the PPAR pathway in the early life of offspringEffects of nutritional components on agingMaternal protein restriction induces early-onset glucose intolerance and alters hepatic genes expression in the peroxisome proliferator-activated receptor pathway in offspring.Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genesLoss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells.Association and interaction of PPARα, δ, and γ gene polymorphisms with low-density lipoprotein-cholesterol in a Chinese Han populationHyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance.Ginkgolide C Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway.Shared Genetic Factors Involved in Celiac Disease, Type 2 Diabetes and Anorexia Nervosa Suggest Common Molecular Pathways for Chronic DiseasesFunctional Analyses of the Crohn's Disease Risk Gene LACC1Programmed regulation of rat offspring adipogenic transcription factor (PPARγ) by maternal nutrition.Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.Dietary protein-induced hepatic IGF-1 secretion mediated by PPARγ activation.Effects of Arsenite Exposure during Fetal Development on Energy Metabolism and Susceptibility to Diet-Induced Fatty Liver Disease in Male Mice.PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ.Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice
P2860
Q24561401-35E46FD3-08F0-4088-BBAC-E3076115BD4BQ26740040-E4B48992-C9A2-483E-9BAE-0BEB4CC2C046Q26745533-DB38A708-5DF9-45BF-8B67-F0E1F2E38282Q26745587-7C7AAE3E-9E07-4148-8CE8-297E5DDB1FDCQ26746981-E87260D2-2426-4BA7-BE57-2F5531FE70EEQ26746998-AF47E0F9-A964-4E5B-B78C-DCFBA4E48E5FQ26765492-2E3D3F21-F0E9-4456-B29C-84B75ACEA972Q26778376-FB1AAF78-BE1A-4FAA-86D7-CE04F9643612Q26800535-8165DD4F-8832-4E60-9759-E6371581A6AAQ28083504-D7C83FF5-ECE9-4253-B682-047F2471EDA6Q28244930-53FA6ECD-461D-4264-AD19-9CDE4DBF92D3Q28831371-DB58BB59-83EB-4999-B8ED-B360FA55D958Q33641104-CAD6E955-CF80-4F65-B208-42884BBE296EQ33747395-C3C1ABD8-4E98-49FF-A518-F761BF2AC90DQ33751973-49A432C8-5B19-4E06-9BBF-8333CA8BAF9CQ33808884-D4CD59FC-87A0-4509-BD39-88C1599ABE2EQ33809886-B3C2AD44-BA3D-4D8B-A6CB-2E01E42A65A9Q33823673-E72E9791-2FB3-4266-BB52-59DE26615ECCQ33838470-3BD0F9EA-E20D-4056-821D-DAD9BD3625D1Q34116406-73FC73DA-C129-48BF-9B78-0870069C603AQ34135528-9AF2E286-A3D6-4671-8BEA-2146FD0DE21DQ34166119-611573C7-BF13-4C25-8EE0-CEEB8C54883EQ34358347-86A978C5-F04F-4E76-BB11-F9504D8B5083Q35080545-1C846FFB-95EC-411F-980F-1BB49BA5CFBDQ35571803-B6F78A3D-7C07-4844-8ADE-F1427A84E7B4Q35613936-24F11172-22BD-4AEB-A637-FEBAAD290AD1Q35677612-72EDED22-4B1C-4FD7-B16B-1F46DA32E201Q35817322-B1C314DB-F16F-4422-B905-5AD293A4A526Q35865309-1D7499E0-CBFC-4925-973C-441BFBC82643Q35905331-68A36BCD-598C-4DA9-A211-4DDE3076E77EQ36054742-4168F7B5-75DD-4877-853F-67352F40B683Q36092441-F15D63D3-C6CA-48C3-94E5-ED46107DB1B1Q36222331-89A10813-2B9B-4787-8D85-AD86DE05B83EQ36240072-DCC8B729-D7A5-4DF7-AB7C-D9312AA9B330Q36261125-1516B972-11B9-4399-8AB5-B16F4529ED93Q36296565-4FF9401D-A434-4970-96F0-7BCD544DCF5CQ36567359-A55E7425-53AE-4D97-9853-8FAA5D2BC15AQ36642430-A5F8E310-42D8-4450-B33F-4962584C009EQ36733126-13EB8D40-86CD-4D81-8BF0-BA0B8F87631CQ36911537-C8A4B96D-B11A-4BE3-A298-C6FB0C4ED173
P2860
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Peroxisome proliferator-activa ...... linical implications--a review
@ast
Peroxisome proliferator-activa ...... linical implications--a review
@en
Peroxisome proliferator-activa ...... linical implications--a review
@nl
type
label
Peroxisome proliferator-activa ...... linical implications--a review
@ast
Peroxisome proliferator-activa ...... linical implications--a review
@en
Peroxisome proliferator-activa ...... linical implications--a review
@nl
prefLabel
Peroxisome proliferator-activa ...... linical implications--a review
@ast
Peroxisome proliferator-activa ...... linical implications--a review
@en
Peroxisome proliferator-activa ...... linical implications--a review
@nl
P2860
P3181
P356
P1433
P1476
Peroxisome proliferator-activa ...... linical implications--a review
@en
P2093
Bogna Grygiel-Górniak
P2860
P2888
P3181
P356
10.1186/1475-2891-13-17
P407
P577
2014-02-14T00:00:00Z
P5875
P6179
1008948571